about
Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelatorSiderophore-based iron acquisition and pathogen controlIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesQuantitative analysis of the anti-proliferative activity of combinations of selected iron-chelating agents and clinically used anti-neoplastic drugsThe Eltrombopag antitumor effect on hepatocellular carcinoma.DNA binding, prominent DNA cleavage and efficient anticancer activities of tris(diimine)iron(II) complexes.Iron metabolism regulates p53 signaling through direct heme-p53 interaction and modulation of p53 localization, stability, and function.The anticancer agent di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes prosurvival autophagy by two mechanisms: persistent induction of autophagosome synthesis and impairment of lysosomal integrity.Nuclear cytoplasmic trafficking of proteins is a major response of human fibroblasts to oxidative stressSubcellular proteomics reveals a role for nucleo-cytoplasmic trafficking at the DNA replication origin activation checkpointA class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics.Oh the irony: Iron as a cancer cause or cure?An iron regulatory gene signature predicts outcome in breast cancer.The neglected significance of "antioxidative stress".Neutrophil gelatinase-associated lipocalin immunoexpression in colorectal carcinoma: A stage-specific prognostic factor?Targeting cancer by binding iron: Dissecting cellular signaling pathwaysCell permeable iron chelators as potential cancer chemotherapeutic agents.Influence of ligand structure on Fe(II) spin-state and redox rate in cytotoxic tripodal chelators.Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberineDifferential targeting of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by chelators with anti-proliferative activity in a range of tumor cell-types.Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells.The heme-p53 interaction: Linking iron metabolism to p53 signaling and tumorigenesis.Effects of ectopic expression of NGAL on doxorubicin sensitivity.Synthetic and natural iron chelators: therapeutic potential and clinical useRETRACTED: Ferroportin in the progression and prognosis of hepatocellular carcinoma.Malaria and iron: history and review.IRP2 regulates breast tumor growth.Metal chelator combined with permeability enhancer ameliorates oxidative stress-associated neurodegeneration in rat eyes with elevated intraocular pressure.Artemisinin derivatives: a patent review (2006 - present).Transfusion related iron overload in pediatric oncology patients treated at a tertiary care centre and treatment with chelation therapy.Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells.Anthocyans as tertiary chemopreventive agents in bladder cancer: anti-oxidant mechanisms and interaction with mitomycin C.Unexpected link between iron and drug resistance of Candida spp.: iron depletion enhances membrane fluidity and drug diffusion, leading to drug-susceptible cells.Post-transcriptional modulation of iron homeostasis during p53-dependent growth arrest.Iron chelator-induced apoptosis via the ER stress pathway in gastric cancer cells.Iron deposition is associated with differential macrophage infiltration and therapeutic response to iron chelation in prostate cancer.Iron imaging reveals tumor and metastasis macrophage hemosiderin deposits in breast cancer.Evaluation of Antioxidative and Cytotoxic Activities of Streptomyces pluripotens MUSC 137 Isolated from Mangrove Soil in Malaysia.Studies of the Antiproliferative Activity of Ruthenium (II) Cyclopentadienyl-Derived Complexes with Nitrogen Coordinated Ligands.(E)-1-(3,4-Dimethyl-benzyl-idene)-2,2-diphenyl-hydrazine.
P2860
Q24652363-249651B5-3086-4212-842D-CEC5476F67F7Q24681774-2F965683-9EFC-40AB-AAF0-9F4C600E3022Q28388335-6361C67A-666B-442F-851C-9A860B793AECQ28539989-7C5FFFDE-3A3B-43A5-849F-7A21E4A09F51Q33426135-3EBA1453-08FE-40A9-9D09-CEC55F61ACA1Q33835903-536C898C-FA67-485D-A4B6-F9CCF2B51F31Q34449959-E857422B-0E0A-44BB-8217-1F984DCD4295Q34580395-D2E329DE-F3D7-4F8F-B695-F432E9951085Q34651070-351E0C56-C932-44E4-9681-E5A794C2931BQ34667732-6C2907C5-1538-4196-8784-E123D1C9B42BQ35075541-47A4B002-C9B0-492F-B7F0-E394F023E1FCQ35343242-BA30BC5C-BC5C-4345-BD9B-732C6FCC2D0EQ35501239-7FA7AA89-072A-4B14-8D6F-B23ECCD27F36Q35977855-C0391BB8-F6D9-45C9-8282-FF36B479CD0FQ36142609-526463FF-254E-4BE4-BF00-B926D3345846Q36326247-3C9B1C28-9534-4AC5-8C25-E9090D3D4D0CQ36353507-6525C4CC-1421-488D-937B-FAB9DD69657CQ36453582-237495C7-A059-4566-BF9E-B1DF648D9099Q36556350-8AC08E42-D6CB-434B-9332-ED6B3EAE2F90Q36557412-14BDE8D5-CAC7-46DB-B68E-E294974F8F98Q36594041-69361182-CFD7-41FA-96D5-1FF3CFF420D4Q36836299-92DEE2F3-F983-44E2-AD8B-01ACDE821D54Q37031268-20D3ABF3-ADF6-48D2-AF4C-964F7BCF7AE8Q37290073-3CEC18A7-B998-412F-A6CB-C3CFF195CC0BQ37426500-FA50C709-D016-420E-BAF5-24B73FBF4757Q37599856-B9E1D5B3-9398-43C4-B906-261EC499B876Q37706902-02088E62-F0E1-4718-B098-0C784B3D07DDQ37734597-E86DF3C5-8AFE-4181-8151-7E9649E8B9F0Q38042732-733E4951-9615-4F5D-A0E5-B5BE6C559E30Q38242978-FDC421AC-2ED1-4DA7-9454-FE58F4B83DC9Q38710822-F085F5DD-62A9-46C1-86ED-8D43478E1187Q39003116-DD85199E-EA2F-4C58-BAEE-9F789DE642EAQ39077878-D8AF2DA9-AB43-421E-A60D-05F6C56EE8D0Q39935350-C3B106EA-0CF4-4151-BC08-904CE53E126AQ40068994-D2CF66A0-6914-4ED1-AAA5-3C1E0E0168A7Q41050245-A90E8AEF-F8C9-4A8F-B4FB-44EE76326A6BQ41229169-9EE91F84-8C40-475A-897A-47F7D1488476Q41976604-D3D91DB4-BC76-425A-906F-5BD046CC10A1Q42109757-8CFF51B5-5406-4B31-B29A-1E1BB74EC199Q42275089-EDD90018-8FF9-4453-A793-E87635EE4245
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Iron chelators in cancer chemotherapy.
@ast
Iron chelators in cancer chemotherapy.
@en
type
label
Iron chelators in cancer chemotherapy.
@ast
Iron chelators in cancer chemotherapy.
@en
prefLabel
Iron chelators in cancer chemotherapy.
@ast
Iron chelators in cancer chemotherapy.
@en
P2093
P356
P1476
Iron chelators in cancer chemotherapy.
@en
P2093
Bryan T Greene
Frank M Torti
Joan L Buss
Jolyn Turner
Suzy V Torti
P304
P356
10.2174/1568026043387269
P577
2004-01-01T00:00:00Z